SELLAS Life Sciences Group, Inc. (NASDAQ: SLS)

$5.01 +0.08 (+1.62%)
As of May 08, 2026 04:00 PM
Sector: Healthcare Industry: Biotechnology CIK: 0001390478
P/E -19.82
Add ratio to table...

About

Statement of Income Location, Balance Breakdown of Revenue (2025)

Peer comparison

Companies in the Biotechnology
S.No. Ticker Company Market Cap P/E P/S Total Debt (Qtr)
1 VRTX Vertex Pharmaceuticals Inc / Ma 109.62 Bn 27.71 9.13 -
2 REGN Regeneron Pharmaceuticals, Inc. 73.93 Bn 16.38 5.15 1.99 Bn
3 ALNY Alnylam Pharmaceuticals, Inc. 40.50 Bn 147.21 12.86 -
4 RVMD Revolution Medicines, Inc. 27.39 Bn -24.25 33,000.01 -
5 ZLAB Zai Lab Ltd 23.74 Bn -135.44 97.90 0.20 Bn
6 MESO Mesoblast Ltd 23.66 Bn -185.34 1,375.67 0.12 Bn
7 RPRX Royalty Pharma plc 21.54 Bn 27.99 9.06 8.95 Bn
8 ROIV Roivant Sciences Ltd. 19.92 Bn -32.48 3,470.34 -